Development of selective inhibitors of dihydrofolate reductase (DHFR) of Mycobacterium tuberculosis
Mycobacterium tuberculosis is the causative organism for one of the pandemic diseases in the world, tuberculosis (TB). The length of treatment often results in multi-drug resistance (MDR) and patient non-compliance. One of the most important enzymes as a drug target for tuberculosis is dihydrofolate...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Bath
2013
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.669020 |